When was Bridge BIO founded?

Bridge BIO was founded in 2015.

Where is Bridge BIO headquartered?

Bridge BIO is headquartered in Seongnam-si, South Korea.

What industry is Bridge BIO in?

Bridge BIO operates in Biotech.

How many employees does Bridge BIO have?

Bridge BIO has 11-50 employees.

Bridge BIO

Seongnam-si, South Korea · Founded 2015

Biotech

Headquarters: Seongnam-si
Employees: 11–50
Founded: 2015

Business Model: B2B
Website: bridgebiorx.com

About

Bridge Biotherapeutics Inc. is a publicly-traded clinical-stage biotechnology company headquartered in Seongnam-si, South Korea, with offices in Cambridge, Massachusetts and China. Founded in 2015 by CEO James Jungkue Lee, the company focuses on discovering and developing novel therapeutics for high unmet medical needs, including ulcerative colitis, fibrotic diseases such as idiopathic pulmonary fibrosis, and cancers including non-small cell lung cancer. Its pipeline features BBT-401 (a first-in-class Pellino-1 inhibitor), BBT-877 (an autotaxin inhibitor for IPF), and BBT-176 (a targeted EGFR-mutant NSCLC therapy).

Summary

Bridge BIO is a Biotech company based in Seongnam-si, South Korea, founded in 2015.